文献速递系统性红斑狼疮

系统性红斑狼疮患者肾脏损伤的预测因素:来自多民族多国拉美狼疮队列(GLADEL)的数据

Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
PubMed 文献 · RMD Open · 2020-01-01

早期治疗反应(12个月内蛋白尿<0.8 g/天)、使用抗疟药和高社会经济地位对肾脏损伤具有保护作用,而男性、高血压和较高的SLEDAI肾脏活动度是肾脏损伤的危险因素。

要点

  • 早期治疗反应(12个月内蛋白尿<0.8 g/天)与肾脏损伤风险降低相关(HR=0.58)。
  • 使用抗疟药和高社会经济地位对肾脏损伤具有保护作用(HR分别为0.54和0.25)。
  • 男性、高血压和较高的SLEDAI肾脏活动度是肾脏损伤的危险因素(HR分别为1.83、1.86和2.02)。

核心结论

  • 早期治疗反应、使用抗疟药和高社会经济地位对狼疮肾炎患者的肾脏损伤具有保护作用。
  • 男性、高血压和较高的SLEDAI肾脏活动度是狼疮肾炎患者发生肾脏损伤的危险因素。

研究设计与样本

  • 研究纳入临床或组织学确诊的狼疮肾炎患者,来自多民族多国拉丁美洲狼疮队列(GLADEL)。
  • 采用Cox回归模型(后退法)分析肾脏损伤的预测因素,肾脏损伤定义为SLICC/ACR损伤指数肾脏域评分增加≥1分。

主要发现

  • 早期治疗反应(12个月内蛋白尿<0.8 g/天)与肾脏损伤风险降低相关(HR=0.58)。
  • 使用抗疟药与肾脏损伤风险降低相关(HR=0.54),高社会经济地位与肾脏损伤风险降低相关(HR=0.25)。
  • 男性与肾脏损伤风险升高相关(HR=1.83),高血压与肾脏损伤风险升高相关(HR=1.86),SLEDAI肾脏活动度与肾脏损伤风险升高相关(HR=2.02)。

关键数值与推荐

  • 早期治疗反应定义为狼疮肾炎诊断后12个月内蛋白尿<0.8 g/天。
  • 肾脏损伤定义为SLICC/ACR损伤指数肾脏域评分增加≥1分。

临床怎么用

  • 对狼疮肾炎患者应关注早期治疗反应,力争在12个月内将蛋白尿控制在<0.8 g/天以降低肾脏损伤风险。
  • 使用抗疟药可能有助于降低狼疮肾炎患者的肾脏损伤风险。
  • 对男性、高血压及SLEDAI肾脏活动度较高的狼疮肾炎患者应加强监测和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: A decrease in proteinuria has been considered protective from renal damage in lupus nephritis (LN), but a cut-off point has yet to be established. The aim of this study was to identify the predictors of renal damage in patients with LN and to determine the best cut-off point for a decrease in proteinuria. METHODS: We included patients with LN defined clinically or histologically. Possible predictors of renal damage at the time of LN diagnosis were examined: proteinuria, low complement, anti-double-stranded DNA antibodies, red cell casts, creatinine level, hypertension, renal activity (assessed by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)), prednisone dose, immunosuppressive drugs and antimalarial use. Sociodemographic variables were included at baseline. Proteinuria was assessed at baseline and at 12 months, to determine if early response (proteinuria <0.8 g/day within 12 months since LN diagnosis) is protective of renal damage occurrence. Renal damage was defined as an increase of one or more points in the renal domain of The Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI). Cox regression models using a backward selection method were performed. RESULTS: Five hundred and two patients with systemic lupus erythematosus patients were included; 120 patients (23.9%) accrued renal damage during their follow-up. Early response to treatment (HR=0.58), antimalarial use (HR=0.54) and a high SES (HR=0.25) were protective of renal damage occurrence, whereas male gender (HR=1.83), hypertension (HR=1.86) and the renal component of the SLEDAI (HR=2.02) were risk factors for its occurrence. CONCLUSIONS: Early response, antimalarial use and high SES were protective of renal damage, while male gender, hypertension and higher renal activity were risk factors for its occurrence in patients with LN.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Reátegui-Sokolova C, Ugarte-Gil MF, Harvey GB, et al. Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL). RMD Open. 2020. PMID: 33310863. doi:10.1136/rmdopen-2020-001299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。